Product Categories
| Country: | China |
|---|---|
| Tel: | 21-61263452 |
| Mobile: | 13641803416 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Company Name: | Shanghai GL Peptide Ltd |
| Tel: | 86-21-61263385 |
| Fax: | 86-21-61263399 |
| Email: | ymbetter@glbiochem |
| WebSite: | http://www.glbiochem.com |
| Nationality: | CHINA |
| Product Name | MF | CAS | Details |
|---|
| [Ser102]-MCC (88-103), MCC (T102S);ANERADLIAYLKQASK | C78H131N23O25 | Details |
| β-Secretase Substrate I, Fluorogenic | Details |
| [Tyr8]-Atrial Natriuretic Peptide (5-27), [Tyr8]-Atriopeptin II, rat;SSCYGGRIDRIGAQSGLGCNSFR(Disulfidebridge:3-19) | C98H156N34O33S2 | Details |
| ?-Neuroprotectin;aDLIAYL-NH2 | C37H60N8O10 | Details |
| Cetrorelix Acid; | C70H92ClN17O14 | 120287-85-6 | Details |
| δ1-MSH, amide | C72H97N21O14S | 72629-65-3 | Details |
| 4A/4B Peptide (3), EDANS-labeled;DEMEECASHLPY-E(EDANS)-NH2 | C76H106N18O27S3 | Details |
| 520 MMP FRET Substrate IV;5-FAM-Pro-Leu-Ala-Nva-Dap(QXL?520)-Ala-Arg-NH2 | Details |
| 520 MMP FRET Substrate XII;5-FAM-RPKPYA-Nva-WM-K(QXL?520)-NH2 | Details |
| 5A, pNA-labeled;EDVV-Abu-C-pNA | C32H48N8O12S | Details |
| [Ala26, Leu27]-Melan-A (26-35);ALAGIGILTV | C43H78N10O12 | Details |
| [pSer5]-Kemptide, HiLyte Fluor? 488 labeled;HiLyteFluor?488-LRRA-pS-LG | Details |
| 490 MMP FRET Substrate V;NBD-RPKPLA-Nva-WK(DMC)-NH2 | C76H109N21O15 | Details |
| [Pyr3]-beta-Amyloid (3-42);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA | C196H299N53O55S1 | 183449-57-2 | Details |
| [4-Chloro-Phe]7,8-Substance P;RPKPQQ-F(4-Cl-F)-GLM-NH2 | C63H96Cl2N18O13S | 73646-81-8 | Details |
| (Arg)9, FAM-labeled;FAM-RRRRRRRRR | C75H120N36O16 | Details |
| (Arg)9, TAMRA-labeled;TAMRA-RRRRRRRRR | C83H134ClN39O16 | Details |
| [Ala144]-PLP (139-151) A144-PLP(139-151);HSLGKALGHPDKF | C64H99N19O17 | Details |
| [D-His26]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALRhYINLITRQRY-NH2 | Details |
| 520 MMP FRET Substrate II;QXL?520-Pro-Leu-Ala-Leu-Trp-Ala-Arg-Lys(5-FAM)-NH2 | C67H86N14O14 | Details |
| Beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV | Details |
| 4A/4B Peptide (2);DEMEECASHLPY-K(Ac)-NH2 | C67H101N17O24S2 | Details |
| [Tyr0]-α-Calcitonin Gene Related Peptide, [Tyr0]-α-CGRP, rat;YSCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2(Disulfidebridge:2-7) | Details |
| [D-Tyr11]-Neurotensin;Pyr-LYENKPRRPyIL | C78H121N21O20 | 39379-15-2 | Details |
| 520 MMP FRET Substrate XVII;QXL?520-Lys-Pro-Leu-Ala-Nva-Dap(5-FAM)-Ala-Arg-NH2 | Details |
| 520 MMP FRET Substrate XI;5-FAM-Pro-Cha-Gly-Nva-His-Ala-Dap(QXL?520)-NH2 | Details |
| [pSer5]-Kemptide, 5-TMR labeled;5-TMR-LRRA-pS-LG | C57H82N15O16P | Details |
| 490 MMP FRET Substrate VI;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Dap(AMCA)-Ala-Arg-NH2 | C64H92N18O12 | Details |
| BREMELANOTIDE | C50H68N14O10 | 189691-06-3 | Details |
| [Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, human, rat;YSEEPPISLDLTFHLLREVLEEMARAEQLAQQAHSNRKLMEII-NH2 | C217H353N61O65S2 | 100513-58-4 | Details |
| 520 MMP FRET Substrate XIV;QXL?520-γ-Abu-Pro-Cha-Abu-Smc-His-Ala-Dab(5-FAM)-Ala-Lys-NH2(Smc=S-Methyl-L-cysteine) | Details |
| 2837b, Hemoglobin Fragment, Plasmepsin II (PM II) substrate, EDANS/ DABCYL??;EDANS-CO-CH2-CH2-CO-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-Dap(DABCYL)-OH | Details |
| [Cys3,6, Tyr8, Pro9]-Substance P;RPCPQCFYPLM-NH2(Disulfidebridge:3-6) | C61H90N16O13S3 | 141459-28-1 | Details |
| γ-2-MSH (41-58), amide;YVMGHFRWDRFG-NH2 | C74H100N22O15S | 799841-81-9 | Details |
| [Gly30, Cys31] β-Amyloid (13-31)??NEW;HHQKLVFFAEDVGSNKGGC | Details |
| [D-Trp6,8,9]-Galanin (1-15)-ol;GWTLNwAwwLLGPHA-ol | C91H120N22O17 | Details |
| [Gln144]-PLP (139-151), Q144-PLP(139-151);HSLGKQLGHPDKF | C66H102N20O18 | Details |
| [pSer5]-Kemptide, Biotinylated-LC;Biotin-LC-LRRA-pS-LG | C48H85N16O15PS | Details |
| [D-Tyr6, ?-Ala11, Phe13, Nle14]-Bombesin (6-14);yQWAV-(?-A)-HF-Nle-NH2 | Details |
| [D-Tyr6, ?-Ala11, ?-Phe13, Nle14]-Bombesin (1-14);Pyr-QRLGyQWAV-(?-A)-H-(?-F)-Nle-NH2 | Details |
| [Tyr0]-Corticotropin Releasing Factor, [Tyr0]-CRF, ovine;YSQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA-NH2 | Details |
| [Deamino-Cys1, D-Arg8]-Vasopressin, free acid;3-Mercaptopropionyl-YFQNCPrG(Disulfidebridge:1-6) | Details |
| 520 MMP FRET Substrate I;QXL520?-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-Lys(5-FAM)-NH2 | Details |
| 520 MMP FRET Substrate IX;QXL?520-RPLALWRK(5-FAM)-NH2 | Details |
| 520 MMP FRET Substrate XIII;5-FAM-RPKPVE-Nva-WRK(QXL?520)-NH2 | Details |
| [Pyr3]-beta-Amyloid (3-40);Pyr-FRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV | C187H283N51O53S | Details |
| [pSer5]-Kemptide, Biotinylated, Amide;Biotin-LRRA-pS-LG-NH2 | C42H77N16O13PS | Details |
| [Lys5, NMeLeu9, NIe10]-Neurokinin A (4-10);DKFVG-(NMeL)-NIe-NH2 | C39H64N8O10 | Details |
| [Leu144]-PLP (139-151), L144-PLP(139-151);HSLGKLLGHPDKF | C67H105N19O17 | Details |
| γ-Endorphin | C83H131N19O27S | 60893-02-9 | Details |
| [Leu28]-Melan-A (27-35);ALGIGILTV | C40H73N9O11 | Details |
| 390 MMP FRET Substrate II;Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-OH | C43H65N11O12 | Details |
| [Ala26]-Melan-A/MART-1 (26-35);AAAGIGILTV | C40H72N10O12 | Details |
| [Tyr22]-α-CGRP (22-37), rat;YVKDNFVPTNVGSEAF-NH2 | Details |
| [3,4-Dehydro-Pro]3-Thyrotropin Releasing Hormone, [ΔPro3]-TRH | Details |
| δ-Endorphin (human) | C139H217N33O40S | 76622-84-9 | Details |
| 520 MMP FRET Substrate V;5-FAM-Pro-Leu-Gly-Leu-Dap(QXL?520)-Ala-Arg-NH2 | Details |
| 520 MMP FRET Substrate VI;QXL?520-Pro-Leu-Gly-Met-Trp-Ser-Arg-Lys(5-FAM)-NH2 | Details |
| 490 MMP FRET Substrate III;DABCYL-RPLALWRS-EDANS | C73H100N20O13S | Details |
| [D-Arg25]-Neuropeptide Y, human, rat;YPSKPDNPGEDAPAEDMARYYSALrHYINLITRQRY-NH2 | Details |
| [Nle35] beta-Amyloid (17-42);LVFFAEDVGSNKGAIIGL-Nle-VGGVVIA | C120H196N28O33 | Details |
| [D-Trp34]-Neuropeptide Y, human;YPSKPDNPGEDAPAEDMARYYSALRHYINLITRwRY-NH2 | Details |
| [Nle35]-Beta-Amyloid (25-35);GSNKGAIIGL-Nle | C46H83N13O14 | 163265-32-5 | Details |
| Ganirelix Acetate | C80H113ClN18O13 | 123246-29-7 | Details |
| δ-Endorphin (bovine, camel, mouse, ovine) | C136H215N35O39S | 66954-40-3 | Details |
| 520 MMP FRET Substrate III;QXL?520-Pro-Leu-Gly-Cys(Me)-His-Ala-Arg-Lys(5-FAM)-NH2 | Details |
| [Nle35]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVV | Details |
| (Z-Arg)2Rh110 ? 2HCl;(Z-R)2Rh110?2HCl | C48H53Cl3N10O9 | Details |
| γ-MSH (3-8) | C39H52N12O7S | 98640-70-1 | Details |
| [pS119] CREB327 (113-126), Biotinyl??;Biotin-ILSRRP(pS)YRKILND | Details |
| [Lys0]-γ-1-MSH (41-58), amide;KYVMGHFRWDRFG-NH2 | C80H112N24O16S | Details |
| [Pyr11]-beta-Amyloid (11-42);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA | C152H242N40O41S | Details |
| [Nle35]-beta-Amyloid (1-42);DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGL-Nle-VGGVVIA | Details |
| [Des-Arg10]-HOE I40;rRP-Hyp-G-Thi-S-(D-Tic)-Oic | C53H77N15O12S | Details |
| [Ile34] Beta-Amyloid (25-34);GSNKGAIIGI | Details |
| [Gly22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAGDVGSNKGAIIGLMVGGVV | Details |
| 520 MMP FRET Substrate VIII;QXL?520-RPKPLA-Nva-WK(5-FAM)-NH2 | Details |
| 520 MMP FRET Substrate XV;QXL?520-γ-Abu-Pro-Gln-Gly-Leu-Dab(5-FAM)-Ala-Lys-NH2 | Details |
| 490 MMP FRET Substrate VII;Dabcyl-Lys-Pro-Leu-Ala-Nva-Dap(AMCA-X)-NH2 | C62H88N14O11 | Details |
| β-Endorphin, equine | Details |
| (Z-AR)2Rh110?2HCl;(Z-AR)2Rh110?HCl | C54H63Cl3N12O11 | Details |
| [Leu27]-Melan-A, MART 1 (26-35);ELAGIGILTV | C45H80N10O14 | Details |
| [Lys4]-Sarafotoxin 6c;CTCKDMTDEECLNFCHQDVIW(Disulfidebridge:1-15and3-11) | C105H157N27O36S5 | Details |
| [Gln22]-beta-Amyloid (1-40);DAEFRHDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV | Details |
| 580 MMP FRET Substrate I;QXL?570-Lys-Pro-Leu-Ala-Nva-Dap(5-TAMRA)-Ala-Arg-NH2 | Details |
| 520 MMP FRET Substrate XVI;QXL?520-RPKPQQFWK(5-FAM)-NH2 | Details |
| 520 MMP FRET Substrate X;QXL?520-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-Lys(5-FAM)-NH2 | Details |
| [Pyr11]-beta-Amyloid (11-40);Pyr-VHHQKLVFFAEDVGSNKGAIIGLMVGGVV | C143H226N38O39S | 192377-94-9 | Details |
| 490 MMP FRET Substrate IV;DabcylPlus-Lys-Pro-Leu-Ala-Nva-Asp(EDANS)-Ala-Arg-NH2 | C66H96N18O13S | Details |
| ?-Bag Cell Peptide;RLRFH | C33H53N13O6 | Details |
| [Tyr11] Head Activator;Pyr-PPGGSKVILY | C54H84N12O15 | Details |
| [Gln22]-beta-Amyloid (6-40);HDSGYEVHHQKLVFFAQDVGSNKGAIIGLMVGGVV | Details |
| 520 MMP FRET Substrate VII;QXL?520-PYAYWMRK(5-FAM)-NH2 | Details |
| (pS8, pS13) Eucariotic Translation Initiation Factor 2B, eIF2B??;RRAAEELDpSRAGpSPQL | Details |
| [Gln11]-beta-Amyloid (1-40);DAEFRHDSGYQVHHQKLVFFAEDVGSNKGAIIGLMVGGVV | C145H210N42O45 | 106686-61-7 | Details |
| γ-TAC4 (30-61)-NH2??;TEAETWEGAGPSIQLQLQEVKTGKASQFFGLM-NH2 | Details |
| [Ala6,D-Trp8]-Galanin (1-15)-ol;GWTLNAAwYLLGPHA-ol | C81H114N20O18 | Details |
| γ3-MSH:GAMMA3-MSH | C126H188N44O37S | 72629-64-2 | Details |
| (Z-Phe-Arg)2Rh110;(Z-FR)2Rh110 | C66H69ClN12O11 | Details |
| [Des-Ac]-α-MSH, amide;SYSMEHFRWGKPV-NH2 | Details |
| Product Total： Product Page： | ||||
| 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 | ||||